sulbactam has been researched along with Empyema, Pleural in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hagiya, H; Harada, K; Otsuka, F | 1 |
| Bartsch, MS; Schäfer, FK; von Bernstorff, W; Warnke, PH; Wiltfang, J | 1 |
2 other study(ies) available for sulbactam and Empyema, Pleural
| Article | Year |
|---|---|
Bilateral massive empyema with bronchopleural fistula.
Topics: Ampicillin; Anti-Bacterial Agents; Bronchial Fistula; Campylobacter Infections; Campylobacter rectus; Clindamycin; Diagnosis, Differential; Drainage; Empyema, Pleural; Fusobacterium Infections; Fusobacterium nucleatum; Humans; Lung Abscess; Male; Middle Aged; Pleural Diseases; Sulbactam; Thoracostomy | 2020 |
[Critical odontogenic infection involving the mediastinum. Case report].
Topics: Abscess; Ampicillin; Cefotaxime; Cellulitis; Combined Modality Therapy; Critical Care; Disease Progression; Empyema, Pleural; Follow-Up Studies; Humans; Male; Mediastinitis; Middle Aged; Neck; Reoperation; Shock, Septic; Staphylococcal Infections; Staphylococcus epidermidis; Streptococcal Infections; Sulbactam; Therapeutic Irrigation; Thoracotomy; Tomography, X-Ray Computed; Vancomycin | 2005 |